Turning Point Therapeutics, Inc. TPTX
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 3.81B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -10.54
- Beta
- -0.19
- Short ratio
- 1.89
- Inst. own
- 92.52%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2022
- 50-d avg
- 75.21
- 200-d avg
- 46.90
- 1y target
- 71.50
News
4 years ago businesswire.com
Bristol Myers Squibb and Turning Point Therapeutics Announce Expiration of HSR Act Waiting Period and Clearance from Federal Cartel Office of Germany Related to Pending Acquisition of Turning Point Therapeutics
NEW YORK & SAN DIEGO--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) (“Turning Point”) today announced the expiration of the waiting period under…
4 years ago businesswire.com
TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Turning Point Therapeutics, Inc. (NASDAQ: TPTX) to Bristol Myers Squibb for $76.00 per…
4 years ago businesswire.com
TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Turning Point…
4 years ago businesswire.com
TURNING POINT THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Turning Point Therapeutics, Inc. - TPTX
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Turning Point…
4 years ago etftrends.com
Biotech ETFs Strengthen as Bristol Myers Squibb Buys Turning Point
Biotechnology sector-related exchange traded funds were in a bright spot on Friday after Bristol Myers Squibb Co. (NYSE: BMY) said it will acquire drug developers Turning Point Therapeutics…
4 years ago newsfilecorp.com
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Turning Point Therapeutics, Inc. Buyout
Wilmington, Delaware--(Newsfile Corp. - June 3, 2022) - Rigrodsky Law, P.A. is investigating Turning Point Therapeutics, Inc. ("Turning Point") (NASDAQ: TPTX) regarding possible breaches of fiduciary…
4 years ago gurufocus.com
Turning Point Therapeutics' Shares Soar on Bristol-Myers Squibb Deal
Turning Point Therapeutics Inc. ( TPTX , Financial) shareholders got a good start to the weekend as the stock soared on news that Bristol-Myers Squibb Co. ( BMY , Financial) is buying the San…
4 years ago prnewswire.com
SHAREHOLDER ALERT: Weiss Law Investigates Turning Point Therapeutics, Inc.
NEW YORK , June 3, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Turning Point Therapeutics, Inc.…
4 years ago invezz.com
Here is Why Turning Point Therapeutics Jumped 110%
Turning Point Therapeutics Inc (NASDAQ: TPTX) jumped 110% after announcing a definitive merger agreement with Bristol Myers Squibb Co (NYSE: BMY). Under the agreement, Bristol Myers Squibb will…
4 years ago invezz.com
Turning Point Therapeutics shares more than doubled on Friday
Shares of Turning Point Therapeutics Inc (NASDAQ: TPTX) more than doubled on Friday after Bristol-Myers Squibb Co (NYSE: BMY) said it will buy the biotech company for $4.10 billion in cash.…
4 years ago businesswire.com
TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Turning Point Therapeutics, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of Turning Point Therapeutics, Inc. (NASDAQ: TPTX) to Bristol Myers Squibb for $76.00 per…
4 years ago investorplace.com
TPTX Stock Soars 115% as Bristol Myers Announces Takeover of Turning Point Therapeutics
Turning Point Therapeutics (TPTX) stock is rocketing higher on Friday following news of a deal with Bristol-Myers Squibb (BMY). The post TPTX Stock Soars 115% as Bristol Myers Announces Takeover of…
-
4 years ago benzinga.com
Mid-Morning Market Update: Markets Open Lower; US Economy Adds 390,000 Jobs In May
U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Friday.
4 years ago barrons.com
Turning Point Stock Doubles After Bristol Myers Announces Takeover
The pharma giant said it would pay $76 a share for the biotech stock, up from Thursday's close of $34.16.
4 years ago pulse2.com
Why Bristol-Myers Squibb (BMY) Is Buying Turning Point Therapeutics (TPTX) In A $4.1 Billion Deal
Bristol Myers Squibb (NYSE: BMY) is buying Turning Point Therapeutics, Inc. (NASDAQ: TPTX) in a $4.1 billion deal. These are the details.
4 years ago marketwatch.com
Turning Point Therapeutics stock more than doubles after Bristol Myers buyout deal valuing company at $3.8 billion
Shares of Turning Point Therapeutics Inc. TPTX, +2.21% more than doubled, up 116.7%, in premarket trading Friday, after the clinical-stage oncology company agreed to be acquired by biopharmaceutical…
4 years ago businesswire.com
Bristol Myers Squibb to Acquire Turning Point Therapeutics, a Leading Precision Oncology Company
NEW YORK & SAN DIEGO--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb (NYSE:BMY) and Turning Point Therapeutics, Inc. (NASDAQ:TPTX) today announced a definitive merger agreement under which…
4 years ago globenewswire.com
Turning Point Therapeutics to Participate in Upcoming Investor Conferences
SAN DIEGO, May 26, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and developing novel targeted therapies for cancer…
4 years ago marketbeat.com
Is Turning Point Therapeutics Stock at a Turning Point?
The volatile stock of Turning Point Therapeutics (NASDAQ: TPTX) is once again piquing the interest of high risk traders after the company announced encouraging data related to a pivotal trial.…
4 years ago stockmarket.com
Best Biotech Stocks To Buy Now? 5 To Know
Check out these biotech stocks with exciting developments today.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 524 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
-
4 years ago benzinga.com
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours:
-
4 years ago benzinga.com
Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.
-
5 years ago benzinga.com
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 342 companies made new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Monday's morning session saw 240 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
This morning 239 companies reached new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
This morning 221 companies reached new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
During the morning session on Thursday, 186 stocks hit new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 148 stocks hit new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Before 10 a.m. ET Friday, 72 stocks made new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
During Tuesday's morning session, 78 stocks hit new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
During Monday's morning session, 127 stocks hit new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
On Wednesday, 109 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
On Monday, 78 companies set new 52-week highs.
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Friday
-
6 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
Stocks That Hit 52-Week Highs On Tuesday
-
7 years ago benzinga.com
46 Stocks Moving In Wednesday's Mid-Day Session
46 Stocks Moving In Wednesday's Mid-Day Session
-
7 years ago benzinga.com
44 Stocks Moving In Monday's Mid-Day Session
44 Stocks Moving In Monday's Mid-Day Session